ADVANCED NUTRACEUTICALS INC/TX
10-Q, EX-27, 2000-08-21
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: ADVANCED NUTRACEUTICALS INC/TX, 10-Q, 2000-08-21
Next: AQUINAS FUNDS INC, N-30D, 2000-08-21



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>                     <C>
<PERIOD-TYPE>                   9-MOS                   9-MOS
<FISCAL-YEAR-END>                          SEP-30-2000             SEP-30-1999
<PERIOD-START>                             OCT-01-1999             OCT-01-1998
<PERIOD-END>                               JUN-30-2000             JUN-30-1999
<CASH>                                         174,068               1,395,310
<SECURITIES>                                         0                 996,942
<RECEIVABLES>                                4,934,916                 362,315
<ALLOWANCES>                                         0                       0
<INVENTORY>                                  8,800,925               8,434,220
<CURRENT-ASSETS>                            17,739,627              14,484,166
<PP&E>                                      20,056,844               9,679,672
<DEPRECIATION>                               5,112,077               3,635,486
<TOTAL-ASSETS>                              43,556,107              22,240,820
<CURRENT-LIABILITIES>                       20,380,488               6,634,899
<BONDS>                                              0                       0
                                0                       0
                                          0                       0
<COMMON>                                        80,198                  58,875
<OTHER-SE>                                  17,085,426              14,289,327
<TOTAL-LIABILITY-AND-EQUITY>                43,556,107              22,240,820
<SALES>                                     52,424,849              50,737,950
<TOTAL-REVENUES>                            52,424,849              50,737,950
<CGS>                                       37,239,784              33,186,954
<TOTAL-COSTS>                               18,551,531              16,103,144
<OTHER-EXPENSES>                               210,952               (469,814)
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                             691,003                  17,064
<INCOME-PRETAX>                            (4,268,421)               1,900,602
<INCOME-TAX>                                 (580,904)                 989,000
<INCOME-CONTINUING>                                  0                       0
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                               (3,687,517)                 911,602
<EPS-BASIC>                                      (.48)                     .16
<EPS-DILUTED>                                    (.48)                     .16


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission